DECISION (Digoxin Evaluation in Chronic heart failure: Investigational Study In Outpatients in the Netherlands)
Sponsor: UMCG (investigator initiated)
The primary objective is to study whether in chronic HF compared to placebo, low-level digoxin reduces (repeated) HF hospitalizations, (repeated) urgent HF hospital visits and cardiovascular mortality, on top of guideline-recommended therapies.
Studyteam:
Sub-I: Marlene Vijver, Geert Voordes.
Studycoordinator: Ester Maas-Soer.
Study consultant: Agaath de Vos